CoronaVR
Efficient MHC-II Binders
| No | Protein | Epitope sequence | Start | Stop | Length | Allele | Conservancy |
|---|---|---|---|---|---|---|---|
| 1 | S | CTFEYVSQPFLMDLE | 165 | 179 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 53.33% (SARS-CoV) |
| 2 | S | TFEYVSQPFLMDLEG | 166 | 180 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 46.67% (SARS-CoV) |
| 3 | S | YRVVVLSFELLHAPA | 507 | 521 | 15 | HLA0DPA1*03:01/DPB1*04:02 | 93.33% (SARS-CoV) |
| 4 | S | RVVVLSFELLHAPAT | 508 | 522 | 15 | HLA0DPA1*03:01/DPB1*04:02 | 93.33% (SARS-CoV) |
| 5 | S | VVVLSFELLHAPATV | 509 | 523 | 15 | HLA0DPA1*03:01/DPB1*04:02 | 93.33% (SARS-CoV) |
| 6 | S | YRVVVLSFELLHAPA | 507 | 521 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 93.33% (SARS-CoV) |
| 7 | S | WTAGAAAYYVGYLQP | 257 | 271 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 66.67% (SARS-CoV) |
| 8 | S | YECDIPIGAGICASY | 659 | 673 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 100% (SARS-CoV) |
| 9 | S | RAAEIRASANLAATK | 1013 | 1027 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 100% (SARS-CoV) |
| 10 | M | VYQLRARSVSPKLFI | 74 | 88 | 15 | HLA0DRB1*01:01 | 33.33% (SARS-CoV) |
| 11 | N | QIGYYRRATRRIRGG | 13 | 27 | 15 | HLA0DRB1*11:01 | 93.33% (SARS-CoV) |
| 12 | N | IGYYRRATRRIRGGD | 14 | 28 | 15 | HLA0DRB1*11:01 | 93.33% (SARS-CoV) |
| 13 | N | GTWLTYTGAIKLDDK | 48 | 62 | 15 | HLA0DRB1*07:01 | 93.33% (SARS-CoV) |
| 14 | N | QIGYYRRATRRIRGG | 13 | 27 | 15 | HLA0DRB5*01:01 | 93.33% (SARS-CoV) |
| 15 | N | TWLTYTGAIKLDDKD | 49 | 63 | 15 | HLA0DRB1*07:01 | 93.33% (SARS-CoV) |
| 16 | N | IGYYRRATRRIRGGD | 14 | 28 | 15 | HLA0DRB5*01:01 | 93.33% (SARS-CoV) |
| 17 | N | WLTYTGAIKLDDKDP | 50 | 64 | 15 | HLA0DRB1*07:01 | 93.33% (SARS-CoV) |
| 18 | N | ATKAYNVTQAFGRRG | 54 | 68 | 15 | HLA0DRB5*01:01 | 93.33% (SARS-CoV) |
| 19 | N | TKAYNVTQAFGRRGP | 55 | 69 | 15 | HLA0DRB5*01:01 | 93.33% (SARS-CoV) |
| 20 | N | QKKQQTVTLLPAADL | 36 | 50 | 15 | HLA0DRB1*01:01 | 86.67% (SARS-CoV) |
| 21 | Leade | LFFFLYENAFLPFAM | 32 | 46 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 80% (SARS-CoV) |
| 22 | Leade | FFFLYENAFLPFAMG | 33 | 47 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 80% (SARS-CoV) |
| 23 | Leade | SLFFFLYENAFLPFA | 31 | 45 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 86.67% (SARS-CoV) |
| 24 | Leade | FFLYENAFLPFAMGI | 34 | 48 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 80% (SARS-CoV) |
| 25 | Leade | WSLFFFLYENAFLPF | 30 | 44 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 93.33% (SARS-CoV) |
| 26 | Leade | KHFYWFFSNYLKRRV | 1 | 15 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 66.67% (SARS-CoV) |
| 27 | Leade | WSLFFFLYENAFLPF | 30 | 44 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 93.33% (SARS-CoV) |
| 28 | Leade | SLFFFLYENAFLPFA | 31 | 45 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 86.67% (SARS-CoV) |
| 29 | Leade | QWSLFFFLYENAFLP | 29 | 43 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 93.33% (SARS-CoV) |
| 30 | Leade | LFFFLYENAFLPFAM | 32 | 46 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 80% (SARS-CoV) |
| 31 | Leade | ILFTRFFYVLGLAAI | 22 | 36 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 73.33% (SARS-CoV) |
| 32 | Leade | YSVIYLYLTFYLTND | 25 | 39 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 86.67% (SARS-CoV) |
| 33 | Leade | LTNIFGTVYEKLKPV | 53 | 67 | 15 | HLA0DPA1*03:01/DPB1*04:02 | 53.33% (SARS-CoV) |
| 34 | Leade | SVIYLYLTFYLTNDV | 26 | 40 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 86.67% (SARS-CoV) |
| 35 | Leade | LAYILFTRFFYVLGL | 19 | 33 | 15 | HLA0DPA1*02:01/DPB1*01:01 | 80% (SARS-CoV) |
| 36 | Leade | VTLVFLFVAAIFYLI | 46 | 60 | 15 | HLA0DPA1*01:03/DPB1*02:01 | 46.67% (SARS-CoV) |
| 37 | Leade | VVMAYITGGVVQLTS | 36 | 50 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 66.67% (SARS-CoV) |
| 38 | Leade | VMAYITGGVVQLTSQ | 37 | 51 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 73.33% (SARS-CoV) |
| 39 | Leade | TFTLKGGAPTKVTFG | 42 | 56 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 53.33% (SARS-CoV) |
| 40 | Leade | MAYITGGVVQLTSQW | 38 | 52 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 80% (SARS-CoV) |
| 41 | Leade | NNTFTLKGGAPTKVT | 40 | 54 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 66.67% (SARS-CoV) |
| 42 | Leade | FTLKGGAPTKVTFGD | 43 | 57 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 53.33% (SARS-CoV) |
| 43 | Leade | LVVMAYITGGVVQLT | 35 | 49 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 60% (SARS-CoV) |
| 44 | Leade | ISASIVAGGIVAIVV | 33 | 47 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 73.33% (SARS-CoV) |
| 45 | Leade | AYITGGVVQLTSQWL | 39 | 53 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 80% (SARS-CoV) |
| 46 | Leade | DISASIVAGGIVAIV | 32 | 46 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 73.33% (SARS-CoV) |
| 47 | Leade | LDISASIVAGGIVAI | 31 | 45 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 80% (SARS-CoV) |
| 48 | Leade | LNRGMVLGSLAATVR | 37 | 51 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 100% (SARS-CoV), 73.33% (MERS-CoV) |
| 49 | Leade | FAMGIIAMSAFAMMF | 44 | 58 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 46.67% (SARS-CoV) |
| 50 | Leade | STYASQGLVASIKNF | 50 | 64 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 86.67% (SARS-CoV) |
| 51 | Leade | FNSTYASQGLVASIK | 48 | 62 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 80% (SARS-CoV) |
| 52 | Leade | ASIVAGGIVAIVVTC | 35 | 49 | 15 | HLA0DQA1*05:01/DQB1*03:01 | 80% (SARS-CoV) |
| 53 | Leade | NYIFWRNTNPIQLSS | 25 | 39 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 54 | Leade | ANYIFWRNTNPIQLS | 24 | 38 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) & 73.33%(MERS-CoV) |
| 55 | Leade | YIFWRNTNPIQLSSY | 26 | 40 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 56 | Leade | HANYIFWRNTNPIQL | 23 | 37 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) & 73.33%(MERS-CoV) |
| 57 | Leade | IFWRNTNPIQLSSYS | 27 | 41 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 58 | Leade | SDEFSSNVANYQKVG | 53 | 67 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 59 | Leade | VGDFKLNEEIAIILA | 44 | 58 | 15 | HLA0DRB3*02:02 | 86.67%(SARS-CoV) |
| 60 | Leade | DEFSSNVANYQKVGM | 54 | 68 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 61 | Leade | GDFKLNEEIAIILAS | 45 | 59 | 15 | HLA0DRB3*02:02 | 86.67%(SARS-CoV) |
| 62 | Leade | KPTVVVNAANVYLKH | 3 | 17 | 15 | HLA0DRB3*02:02 | 66.67% (SARS-CoV) |
| 63 | Leade | LTFYLTNDVSFLAHI | 32 | 46 | 15 | HLA0DRB3*02:02 | 86.67%(SARS-CoV) |
| 64 | Leade | MHANYIFWRNTNPIQ | 22 | 36 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) & 73.33%(MERS-CoV) |
| 65 | Leade | YLTFYLTNDVSFLAH | 31 | 45 | 15 | HLA0DRB3*02:02 | 93.33%(SARS-CoV) |
| 66 | Leade | EETFKLSYGIATVRE | 6 | 20 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 67 | Leade | TEETFKLSYGIATVR | 5 | 19 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 68 | Leade | ILRVYANLGERVRQA | 13 | 27 | 15 | HLA0DRB3*02:02 | 93.33%(SARS-CoV) |
| 69 | Leade | EFSSNVANYQKVGMQ | 55 | 69 | 15 | HLA0DRB3*02:02 | 100%(SARS-CoV) |
| 70 | Leade | SPFVMMSAPPAQYEL | 52 | 66 | 15 | HLA0DRB1*01:01 | 80%(SARS-CoV) |
| 71 | Leade | PFVMMSAPPAQYELK | 53 | 67 | 15 | HLA0DRB1*01:01 | 73.33%(SARS-CoV) |
| 72 | Leade | QQESPFVMMSAPPAQ | 49 | 63 | 15 | HLA0DRB1*01:01 | 86.67%(SARS-CoV) |
| 73 | Leade | FVMMSAPPAQYELKH | 54 | 68 | 15 | HLA0DRB1*01:01 | 73.33%(SARS-CoV) |
| 74 | Leade | KPTVVVNAANVYLKH | 3 | 17 | 15 | HLA0DRB1*13:02 | 66.67% (SARS-CoV) |
| 75 | Leade | PEVKILNNLGVDIAA | 9 | 23 | 15 | HLA0DRB1*13:02 | 93.33%(SARS-CoV) |
| 76 | Leade | PTVVVNAANVYLKHG | 4 | 18 | 15 | HLA0DRB1*13:02 | 73.33%(SARS-CoV) |
| 77 | Leade | FSAVGNICYTPSKLI | 19 | 33 | 15 | HLA0DRB1*07:01 | 100%(SARS-CoV) |
| 78 | Leade | KGRLIIRENNRVVIS | 5 | 19 | 15 | HLA0DRB1*13:02 | 93.33%(SARS-CoV) |
| 79 | Leade | LDAYNMMISAGFSLW | 50 | 64 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 80 | Leade | LKYAISAKNRARTVA | 36 | 50 | 15 | HLA0DRB5*01:01 | 100%(SARS-CoV), 100%(MERS-CoV), 80%NL(63), 100%OC(43), 100%HKU(1), 80%229E |
| 81 | Leade | VVYRGTTTYKLNVGD | 3 | 17 | 15 | HLA0DRB1*07:01 | 100%(SARS-CoV), 80%OC(43) , 73.33%HKU(1) |
| 82 | Leade | SAFYILPSIISNEKQ | 21 | 35 | 15 | HLA0DRB1*11:01 | 60% (SARS-CoV) |
| 83 | Leade | CRKVQHMVVKAALLA | 4 | 18 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV) |
| 84 | Leade | GSLIYSTAALGVLMS | 1 | 15 | 15 | HLA0DRB1*07:01 | 73.33%(SARS-CoV) |
| 85 | Leade | HLIPLMYKGLPWNVV | 53 | 67 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 86 | Leade | EKQEILGTVSWNLRE | 33 | 47 | 15 | HLA0DRB1*07:01 | 86.67%(SARS-CoV) |
| 87 | Leade | KQEILGTVSWNLREM | 34 | 48 | 15 | HLA0DRB1*07:01 | 93.33%(SARS-CoV) |
| 88 | Leade | VLLSVLQQLRVESSS | 21 | 35 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) & 73.33%(MERS-CoV) |
| 89 | Leade | SLIYSTAALGVLMSN | 2 | 16 | 15 | HLA0DRB1*07:01 | 73.33%(SARS-CoV) |
| 90 | Leade | QWMVMFTPLVPFWIT | 47 | 61 | 15 | HLA0DRB1*01:01 | 73.33%(SARS-CoV) |
| 91 | Leade | QKLALGGSVAIKITE | 27 | 41 | 15 | HLA0DRB1*07:01 | 86.67%(SARS-CoV), 86.67%(MERS-CoV), 86.67%NL(63), 93%OC(43), 86.67%HKU(1), 73.33%229E |
| 92 | Leade | RFNVAITRAKVGILC | 4 | 18 | 15 | HLA0DRB5*01:01 | 93.33%(SARS-CoV), 86.67%(MERS-CoV), 86.67%NL(63), 93%OC(43), 86.67%HKU(1), 86.67%229E |
| 93 | Leade | ASEFSSLPSYAAFAT | 25 | 39 | 15 | HLA0DRB1*04:01 | 93.33%(SARS-CoV) |
| 94 | Leade | KSNHNFLVQAGNVQL | 34 | 48 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV) |
| 95 | Leade | VVLLILMTARTVYDD | 49 | 63 | 15 | HLA0DRB1*15:01 | 93.33%(SARS-CoV) |
| 96 | Leade | GLHLLIGLAKRFKES | 49 | 63 | 15 | HLA0DRB5*01:01 | 73.33%(SARS-CoV), 73.33% (MERS-CoV) |
| 97 | Leade | LNVGDYFVLTSHTVM | 13 | 27 | 15 | HLA0DRB1*07:01 | 100%(SARS-CoV) & 73.33%(MERS-CoV), 73.33%OC(43) |
| 98 | Leade | TVREVLSDRELHLSW | 17 | 31 | 15 | HLA0DRB1*03:01 | 100%(SARS-CoV) |
| 99 | Leade | ASAVVLLILMTARTV | 46 | 60 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV) |
| 100 | Leade | YLDAYNMMISAGFSL | 49 | 63 | 15 | HLA0DRB1*07:01 | 100%(SARS-CoV) |
| 101 | Leade | SVYYSQLMCQPILLL | 38 | 52 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 102 | Leade | VYYSQLMCQPILLLD | 39 | 53 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 103 | Leade | WNTFTRLQSLENVAF | 5 | 19 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV), 80% OC(43), 80%HKU(1) |
| 104 | Leade | YILFTRFFYVLGLAA | 21 | 35 | 15 | HLA0DRB1*01:01 | 73.33%(SARS-CoV) |
| 105 | Leade | LHLLIGLAKRFKESP | 50 | 64 | 15 | HLA0DRB1*11:01 | 73.33%(SARS-CoV) |
| 106 | Leade | IAMSAFAMMFVKHKH | 49 | 63 | 15 | HLA0DRB5*01:01 | 60% (SARS-CoV) |
| 107 | Leade | HLLIGLAKRFKESPF | 51 | 65 | 15 | HLA0DRB1*11:01 | 66.67% (SARS-CoV) |
| 108 | Leade | LYFIKGLNNLNRGMV | 28 | 42 | 15 | HLA0DRB1*04:05 | 100%(SARS-CoV), 73.33%(MERS-CoV), 73.33%HKU(1), 73.33% 229E |
| 109 | Leade | KPNELSRVLGLKTLA | 9 | 23 | 15 | HLA0DRB1*01:01 | 80%(SARS-CoV) |
| 110 | Leade | LTQYNRYLALYNKYK | 51 | 65 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 111 | Leade | CTSVVLLSVLQQLRV | 17 | 31 | 15 | HLA0DRB1*01:01 | 73.33%(SARS-CoV), 86.67% (MERS-CoV) |
| 112 | Leade | LDAYNMMISAGFSLW | 50 | 64 | 15 | HLA0DRB1*07:01 | 100%(SARS-CoV) |
| 113 | Leade | NQHEVLLAPLLSAGI | 19 | 33 | 15 | HLA0DRB1*01:01 | 73.33%(SARS-CoV) |
| 114 | Leade | VQQESPFVMMSAPPA | 48 | 62 | 15 | HLA0DRB1*09:01 | 93.33%(SARS-CoV) |
| 115 | Leade | FKVTKGKAKKGAWNI | 19 | 33 | 15 | HLA0DRB5*01:01 | 80%(SARS-CoV) |
| 116 | Leade | SEFSSLPSYAAFATA | 26 | 40 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV) |
| 117 | Leade | ASEFSSLPSYAAFAT | 25 | 39 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV) |
| 118 | Leade | NFNVLFSTVFPPTSF | 14 | 28 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 119 | Leade | CYDHVISTSHKLVLS | 34 | 48 | 15 | HLA0DRB1*07:01 | 100%(SARS-CoV), 80%(MERS-CoV), 73.33%OC(43), 73.33% HKU(1) |
| 120 | Leade | REVLSDRELHLSWEV | 19 | 33 | 15 | HLA0DRB1*03:01 | 100%(SARS-CoV) |
| 121 | Leade | VITFDNLKTLLSLRE | 10 | 24 | 15 | HLA0DRB1*01:01 | 66.67% (SARS-CoV) |
| 122 | Leade | QFKHLIPLMYKGLPW | 50 | 64 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV), 73.33%(MERS-CoV), 73.33%NL(63), 73.33%OC(43), 73.33% HKU(1) |
| 123 | Leade | FLMSFTVLCLTPVYS | 5 | 19 | 15 | HLA0DRB1*01:01 | 80%(SARS-CoV) |
| 124 | Leade | TYICGFIQQKLALGG | 19 | 33 | 15 | HLA0DRB1*01:01 | 86.67%(SARS-CoV), 73.33%OC(43), 73.33% 229E |
| 125 | Leade | TKGGRFVLALLSDLQ | 45 | 59 | 15 | HLA0DRB1*01:01 | 86.67%(SARS-CoV) |
| 126 | Leade | LEPEYFNSVCRLMKT | 1 | 15 | 15 | HLA0DRB1*11:01 | 100%(SARS-CoV), 73.33%(MERS-CoV) |
| 127 | Leade | EASFNYLKSPNFSKL | 42 | 56 | 15 | HLA0DRB1*04:01 | 66.67% (SARS-CoV) |
| 128 | Leade | LDAYNMMISAGFSLW | 50 | 64 | 15 | HLA0DRB1*09:01 | 100%(SARS-CoV) |
| 129 | Leade | SIDAFKLNIKLLGVG | 54 | 68 | 15 | HLA0DRB1*11:01 | 93.33%(SARS-CoV) |
| 130 | Leade | FCLEASFNYLKSPNF | 39 | 53 | 15 | HLA0DRB1*04:05 | 60% (SARS-CoV) |
| 131 | Leade | AFYILPSIISNEKQE | 22 | 36 | 15 | HLA0DRB1*11:01 | 60% (SARS-CoV) |
| 132 | Leade | VLFSTVFPPTSFGPL | 17 | 31 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 133 | Leade | FTYICGFIQQKLALG | 18 | 32 | 15 | HLA0DRB1*01:01 | 86.67%(SARS-CoV), 73.33%OC(43), 73.33% 229E |
| 134 | Leade | TFDNLKTLLSLREVR | 12 | 26 | 15 | HLA0DRB1*01:01 | 66.67% (SARS-CoV) |
| 135 | Leade | FLHFLPRVFSAVGNI | 11 | 25 | 15 | HLA0DRB1*11:01 | 100%(SARS-CoV) |
| 136 | Leade | QFKHLIPLMYKGLPW | 50 | 64 | 15 | HLA0DRB5*01:01 | 100%(SARS-CoV), 73.33%(MERS-CoV), 73.33%NL(63), 73.33%OC(43), 73.33% HKU(1) |
| 137 | Leade | FLAHIQWMVMFTPLV | 42 | 56 | 15 | HLA0DRB1*01:01 | 66.67% (SARS-CoV) |
| 138 | Leade | ALFAYTKRNVIPTIT | 18 | 32 | 15 | HLA0DRB1*11:01 | 100%(SARS-CoV), 80% (MERS-CoV), 80%NL63 |
| 139 | Leade | DNLKTLLSLREVRTI | 14 | 28 | 15 | HLA0DRB1*01:01 | 80%(SARS-CoV) |
| 140 | Leade | AYITGGVVQLTSQWL | 39 | 53 | 15 | HLA0DRB1*01:01 | 80%(SARS-CoV) |
| 141 | Leade | LATVAYFNMVYMPAS | 4 | 18 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 142 | Leade | FDNLKTLLSLREVRT | 13 | 27 | 15 | HLA0DRB1*01:01 | 73.33%(SARS-CoV) |
| 143 | Leade | AIASEFSSLPSYAAF | 23 | 37 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV) |
| 144 | Leade | KHFYWFFSNYLKRRV | 1 | 15 | 15 | HLA0DRB1*11:01 | 66.67% (SARS-CoV) |
| 145 | Leade | NSIDAFKLNIKLLGV | 53 | 67 | 15 | HLA0DRB1*11:01 | 86.67%(SARS-CoV) |
| 146 | Leade | DALFAYTKRNVIPTI | 17 | 31 | 15 | HLA0DRB1*11:01 | 100%(SARS-CoV), 80% (MERS-CoV), 80%NL63 |
| 147 | Leade | FMGRIRSVYPVASPN | 16 | 30 | 15 | HLA0DRB1*01:01 | 93.33%(SARS-CoV) |
| 148 | Leade | WLIINLVQMAPISAM | 56 | 70 | 15 | HLA0DRB4*01:01 | 73.33%(SARS-CoV) |
| 149 | Leade | IYSTAALGVLMSNLG | 4 | 18 | 15 | HLA0DRB1*07:01 | 66.67% (SARS-CoV) |
| 150 | Leade | PAMHAASGNLLLDKR | 10 | 24 | 15 | HLA0DRB1*01:01 | 100%(SARS-CoV) |
| 151 | Leade | FNVAITRAKVGILCI | 5 | 19 | 15 | HLA0DRB5*01:01 | 93.33%(SARS-CoV), 80%(MERS-CoV), 80%NL(63), 86.67%OC(43), 80% HKU(1), 86.67%229E |
| 152 | Leade | LYLDAYNMMISAGFS | 48 | 62 | 15 | HLA0DRB1*09:01 | 93.33%(SARS-CoV) |
| 153 | Leade | FGLFCLLNRYFRLTL | 14 | 28 | 15 | HLA0DRB5*01:01 | 100%(SARS-CoV) |
| 154 | ORF3a | KKRWQLALSKGVHFV | 66 | 80 | 15 | HLA0DRB1*07:01 | 66.67% (SARS-CoV) |
| 155 | ORF3a | TPSDFVRATATIPIQ | 24 | 38 | 15 | HLA0DRB1*07:01 | 60% (SARS-CoV) |
| 156 | ORF3a | LKKRWQLALSKGVHF | 65 | 79 | 15 | HLA0DRB1*07:01 | 73.33% (SARS-CoV) |
| 157 | ORF3a | LKKRWQLALSKGVHF | 65 | 79 | 15 | HLA0DRB1*01:01 | 73.33% (SARS-CoV) |
| 158 | ORF3a | PSDFVRATATIPIQA | 25 | 39 | 15 | HLA0DRB1*07:01 | 66.67% (SARS-CoV) |
| 159 | ORF3a | KRWQLALSKGVHFVC | 67 | 81 | 15 | HLA0DRB1*07:01 | 73.33% (SARS-CoV) |
| 160 | ORF3a | SDFVRATATIPIQAS | 26 | 40 | 15 | HLA0DRB1*07:01 | 66.67% (SARS-CoV) |
| 161 | ORF3a | LKKRWQLALSKGVHF | 65 | 79 | 15 | HLA0DRB5*01:01 | 73.33% (SARS-CoV) |
| 162 | ORF3a | KKRWQLALSKGVHFV | 66 | 80 | 15 | HLA0DRB5*01:01 | 66.67% (SARS-CoV) |
| 163 | ORF3a | ASKIITLKKRWQLAL | 59 | 73 | 15 | HLA0DRB1*11:01 | 80% (SARS-CoV) |
| 164 | ORF3a | SASKIITLKKRWQLA | 58 | 72 | 15 | HLA0DRB1*11:01 | 80% (SARS-CoV) |
| 165 | ORF3a | SKIITLKKRWQLALS | 60 | 74 | 15 | HLA0DRB1*11:01 | 73.33% (SARS-CoV) |
| 166 | ORF3a | TLKKRWQLALSKGVH | 64 | 78 | 15 | HLA0DRB1*01:01 | 66.67% (SARS-CoV) |
| 167 | ORF3a | KKRWQLALSKGVHFV | 66 | 80 | 15 | HLA0DRB1*09:01 | 66.67% (SARS-CoV) |
| 168 | ORF3a | LKKRWQLALSKGVHF | 65 | 79 | 15 | HLA0DRB1*09:01 | 73.33% (SARS-CoV) |
| 169 | ORF3a | LYALVYFLQSINFVR | 108 | 122 | 15 | HLA0DRB1*01:01 | 73.33% (SARS-CoV) |
| 170 | ORF3a | LYALVYFLQSINFVR | 108 | 122 | 15 | HLA0DRB5*01:01 | 73.33% (SARS-CoV) |
| 171 | ORF3a | DLFMRIFTIGTVTLK | 2 | 16 | 15 | HLA0DRB1*01:01 | 53.33% (SARS-CoV) |
| 172 | ORF3a | LFMRIFTIGTVTLKQ | 3 | 17 | 15 | HLA0DRB1*01:01 | 46.67% (SARS-CoV) |
| 173 | ORF3a | MDLFMRIFTIGTVTL | 1 | 15 | 15 | HLA0DRB1*01:01 | 60% (SARS-CoV) |
| 174 | ORF3a | SHLLLVAAGLEAPFL | 92 | 106 | 15 | HLA0DRB1*01:01 | 86.67% (SARS-CoV) |
| 175 | ORF3a | ITLKKRWQLALSKGV | 63 | 77 | 15 | HLA0DRB1*09:01 | 73.33% (SARS-CoV) |
| 176 | ORF3a | FMRIFTIGTVTLKQG | 4 | 18 | 15 | HLA0DRB1*01:01 | 40% (SARS-CoV) |
| 177 | ORF3a | LLFVTVYSHLLLVAA | 85 | 99 | 15 | HLA0DRB1*01:01 | 93.33% (SARS-CoV) |
| 178 | ORF3a | YLYALVYFLQSINFV | 107 | 121 | 15 | HLA0DRB1*01:01 | 73.33% (SARS-CoV) |
| 179 | ORF3a | ALVYFLQSINFVRII | 110 | 124 | 15 | HLA0DPA1*01:03/DPB1*04:01 | 73.33% (SARS-CoV) |
| 180 | ORF7a | VYQLRARSVSPKLFI | 74 | 88 | 15 | HLA0DRB1*01:01 | 93.33% (SARS-CoV) |
| 181 | ORF8 | YSKWYIRVGARKSAP | 42 | 56 | 15 | HLA0DRB1*11:01 | 26.67% (SARS-CoV) |
| 182 | ORF8 | SKWYIRVGARKSAPL | 43 | 57 | 15 | HLA0DRB1*11:01 | 26.67% (SARS-CoV) |
| 183 | ORF8 | KWYIRVGARKSAPLI | 44 | 58 | 15 | HLA0DRB1*11:01 | 26.67% (SARS-CoV) |
| 184 | ORF8 | FYSKWYIRVGARKSA | 41 | 55 | 15 | HLA0DRB1*11:01 | 26.67% (SARS-CoV) |
| 185 | ORF8 | FYSKWYIRVGARKSA | 41 | 55 | 15 | HLA0DRB5*01:01 | 26.67% (SARS-CoV) |
| 186 | ORF8 | YSKWYIRVGARKSAP | 42 | 56 | 15 | HLA0DRB5*01:01 | 26.67% (SARS-CoV) |
| 187 | ORF8 | SKWYIRVGARKSAPL | 43 | 57 | 15 | HLA0DRB5*01:01 | 26.67% (SARS-CoV) |
| 188 | ORF8 | QPYVVDDPCPIHFYS | 29 | 43 | 15 | HLA0DRB3*01:01 | 20% (SARS-CoV) |
| 189 | ORF8 | KWYIRVGARKSAPLI | 44 | 58 | 15 | HLA0DRB5*01:01 | 26.67% (SARS-CoV) |
| 190 | ORF8 | KWYIRVGARKSAPLI | 44 | 58 | 15 | HLA0DRB1*01:01 | 26.67% (SARS-CoV) |
| 191 | ORF8 | WYIRVGARKSAPLIE | 45 | 59 | 15 | HLA0DRB1*01:01 | 26.67% (SARS-CoV) |
| 192 | ORF8 | HFYSKWYIRVGARKS | 40 | 54 | 15 | HLA0DRB1*01:01 | 20% (SARS-CoV) |
| 193 | ORF8 | PCPIHFYSKWYIRVG | 36 | 50 | 15 | HLA0DRB1*15:01 | 20% (SARS-CoV) |
| 194 | ORF8 | FLGIITTVAAFHQEC | 6 | 20 | 15 | HLA0DRB1*01:01 | 26.67% (SARS-CoV) |